These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 7585661)
1. Transforming growth factor beta and cancer. Nørgaard P; Hougaard S; Poulsen HS; Spang-Thomsen M Cancer Treat Rev; 1995 Jul; 21(4):367-403. PubMed ID: 7585661 [No Abstract] [Full Text] [Related]
2. Transforming growth factor-beta: the breaking open of a black box. Alevizopoulos A; Mermod N Bioessays; 1997 Jul; 19(7):581-91. PubMed ID: 9230691 [TBL] [Abstract][Full Text] [Related]
3. Expression and secretion of TGF-beta isoforms and expression of TGF-beta-receptors I, II and III in normal and neoplastic human breast. Chakravarthy D; Green AR; Green VL; Kerin MJ; Speirs V Int J Oncol; 1999 Jul; 15(1):187-94. PubMed ID: 10375614 [TBL] [Abstract][Full Text] [Related]
4. [TGF-beta signaling and carcinogenesis]. Kahata K; Asaka M; Miyazono K Nihon Rinsho; 2005 Apr; 63 Suppl 4():549-54. PubMed ID: 15861709 [No Abstract] [Full Text] [Related]
5. The transforming growth factor-beta system and the kidney. Sharma K; Ziyadeh FN Semin Nephrol; 1993 Jan; 13(1):116-28. PubMed ID: 8381979 [No Abstract] [Full Text] [Related]
7. Characterization of TGF-beta-regulated interleukin-8 expression in human prostate cancer cells. Lu S; Dong Z Prostate; 2006 Jun; 66(9):996-1004. PubMed ID: 16541418 [TBL] [Abstract][Full Text] [Related]
8. Loss of responsiveness to transforming growth factor beta induces malignant transformation of nontumorigenic rat prostate epithelial cells. Tang B; de Castro K; Barnes HE; Parks WT; Stewart L; Böttinger EP; Danielpour D; Wakefield LM Cancer Res; 1999 Oct; 59(19):4834-42. PubMed ID: 10519393 [TBL] [Abstract][Full Text] [Related]
9. [TGF-beta and its receptors]. Yuasa Y Gan To Kagaku Ryoho; 1997 Sep; 24(11):1460-4. PubMed ID: 9309142 [TBL] [Abstract][Full Text] [Related]
10. TGF-beta signaling: positive and negative effects on tumorigenesis. Wakefield LM; Roberts AB Curr Opin Genet Dev; 2002 Feb; 12(1):22-9. PubMed ID: 11790550 [TBL] [Abstract][Full Text] [Related]
12. A soluble transforming growth factor beta type III receptor suppresses tumorigenicity and metastasis of human breast cancer MDA-MB-231 cells. Bandyopadhyay A; Zhu Y; Cibull ML; Bao L; Chen C; Sun L Cancer Res; 1999 Oct; 59(19):5041-6. PubMed ID: 10519421 [TBL] [Abstract][Full Text] [Related]